Skip to content

Clinical study of esketamine in postoperative patient-controlled intravenous analgesia in burn patients

Clinical study of esketamine in postoperative patient-controlled intravenous analgesia in burn patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058258
Enrollment
Unknown
Registered
2022-04-04
Start date
2022-03-31
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burn

Interventions

Experimental group:Esketamine was used for intravenous patient-controlled analgesia (PCIA)

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing burn skin grafting under general anesthesia; 2. Aged 13-80 years; 3. ASA grade ?-?, BMI 18-30; 4. Clear consciousness, basic reading comprehension ability, vision and hearing basic normal; 5. No history of mental illness or cognitive dysfunction, able to express their feelings in language; 6. Volunteer to participate in this study, understand and sign informed consent, and cooperate with the completion of intervention and assessment.

Exclusion criteria

Exclusion criteria: 1. Allergic or contraindicated to the use of drugs and excipients in surgery and postoperative analgesia; 2. Participate in other clinical studies within 3 months before being enrolled in this study; 3. Patients with severe compound injury; 4. Patients with dysfunction of heart, lung and other important organs; 5. Be pregnant.

Design outcomes

Primary

MeasureTime frame
15-item Recovery Quality Scoring Scale (QoR-15);Emotional Self-Rating Scale (DASS-21);Pain score;

Secondary

MeasureTime frame
Rescue analgesia;Adverse reactions;Pain, inflammation and mood factors;

Countries

China

Contacts

Public ContactYan Wenjun
gsywj2008@hotmail.com+86 13893370700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026